ResearcherXiamen UniversityActive in the last 2 years

Changsheng Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4297-364X; OpenAlex author ID A5112310587. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

Synergic value of 3D CT-derived body composition and triglyceride glucose body mass for survival prognostic modeling in unresectable pancreatic cancer. Co-author DOI 10.3389/fnut.2025.1499188 ↗
Keratin19 promotes pancreatic cancer progression and poor prognosis via activating the Hedgehog pathway. Co-author DOI 10.3892/ijo.2023.5491 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xinbo Wang · 1 shared paper, 2025 · strength 0.26
- Paper Synergic value of 3D CT-derived body composition and triglyceride glucose body mass for survival prognostic modeling in… DOI 10.3389/fnut.2025.1499188 ↗
Xinying Wang · 1 shared paper, 2025 · strength 0.26
- Paper Synergic value of 3D CT-derived body composition and triglyceride glucose body mass for survival prognostic modeling in… DOI 10.3389/fnut.2025.1499188 ↗
Kangjing Xu · 1 shared paper, 2025 · strength 0.26
- Paper Synergic value of 3D CT-derived body composition and triglyceride glucose body mass for survival prognostic modeling in… DOI 10.3389/fnut.2025.1499188 ↗
Wengang Li · 1 shared paper, 2023 · strength 0.22
- Paper Keratin19 promotes pancreatic cancer progression and poor prognosis via activating the Hedgehog pathway. DOI 10.3892/ijo.2023.5491 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.